Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence.

Clinical neuropharmacology

Takaki M, Ishikawa R, Sakamoto S, Hashimoto N, Okahisa Y, Yamada N.
PMID: 34966042
Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):11-12. doi: 10.1097/WNF.0000000000000488.

OBJECTIVE: Benzodiazepine (BZD) dependence has become a social problem and results in poor outcomes. Only a few evidence-based treatments for pharmacotherapy, including antidepressants, are recommended.METHODS: We reported about a 71-year-old man with onset of blindness at 50 years of...

Cite
Takaki M, Ishikawa R, Sakamoto S, et al. Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clin Neuropharmacol. 2022;45(1):11-12doi: 10.1097/WNF.0000000000000488.
Takaki, M., Ishikawa, R., Sakamoto, S., Hashimoto, N., Okahisa, Y., & Yamada, N. (2022). Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clinical neuropharmacology, 45(1), 11-12. https://doi.org/10.1097/WNF.0000000000000488
Takaki, Manabu, et al. "Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence." Clinical neuropharmacology vol. 45,1 (2022): 11-12. doi: https://doi.org/10.1097/WNF.0000000000000488
Takaki M, Ishikawa R, Sakamoto S, Hashimoto N, Okahisa Y, Yamada N. Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):11-12. doi: 10.1097/WNF.0000000000000488. PMID: 34966042.
Copy Download .nbib Format: NLM
Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence.

Clinical neuropharmacology

Takaki M, Ishikawa R, Sakamoto S, Hashimoto N, Okahisa Y, Yamada N.
PMID: 34966042
Clin Neuropharmacol. 2021 Dec 23; doi: 10.1097/WNF.0000000000000488. Epub 2021 Dec 23.

OBJECTIVE: Benzodiazepine (BZD) dependence has become a social problem and results in poor outcomes. Only a few evidence-based treatments for pharmacotherapy, including antidepressants, are recommended.METHODS: We reported about a 71-year-old man with onset of blindness at 50 years of...

Cite
Takaki M, Ishikawa R, Sakamoto S, et al. Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clin Neuropharmacol. 2021;doi: 10.1097/WNF.0000000000000488.
Takaki, M., Ishikawa, R., Sakamoto, S., Hashimoto, N., Okahisa, Y., & Yamada, N. (2021). Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clinical neuropharmacology, . https://doi.org/10.1097/WNF.0000000000000488
Takaki, Manabu, et al. "Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence." Clinical neuropharmacology vol. (2021). doi: https://doi.org/10.1097/WNF.0000000000000488
Takaki M, Ishikawa R, Sakamoto S, Hashimoto N, Okahisa Y, Yamada N. Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clin Neuropharmacol. 2021 Dec 23; doi: 10.1097/WNF.0000000000000488. Epub 2021 Dec 23. PMID: 34966042.
Copy Download .nbib Format: NLM
Supplementation With Dexmedetomidine for Transsphenoidal Resection of Pituitary Adenoma: "Security Points".

Clinical neuropharmacology

Niño MC, Cohen D, Mejía JA, Moyano L, González M, Vallejo MG.
PMID: 34380960
Clin Neuropharmacol. 2021 Sep-Oct 01;44(5):198-199. doi: 10.1097/WNF.0000000000000468.

No abstract available.

Cite
Niño MC, Cohen D, Mejía JA, et al. Supplementation With Dexmedetomidine for Transsphenoidal Resection of Pituitary Adenoma: "Security Points". Clin Neuropharmacol. 2021;44(5):198-199doi: 10.1097/WNF.0000000000000468.
Niño, M. C., Cohen, D., Mejía, J. A., Moyano, L., González, M., & Vallejo, M. G. (2021). Supplementation With Dexmedetomidine for Transsphenoidal Resection of Pituitary Adenoma: "Security Points". Clinical neuropharmacology, 44(5), 198-199. https://doi.org/10.1097/WNF.0000000000000468
Niño, Maria Claudia, et al. "Supplementation With Dexmedetomidine for Transsphenoidal Resection of Pituitary Adenoma: "Security Points"." Clinical neuropharmacology vol. 44,5 (2021): 198-199. doi: https://doi.org/10.1097/WNF.0000000000000468
Niño MC, Cohen D, Mejía JA, Moyano L, González M, Vallejo MG. Supplementation With Dexmedetomidine for Transsphenoidal Resection of Pituitary Adenoma: "Security Points". Clin Neuropharmacol. 2021 Sep-Oct 01;44(5):198-199. doi: 10.1097/WNF.0000000000000468. PMID: 34380960.
Copy Download .nbib Format: NLM
The spinocerebellar ataxias.

Clinical neuropharmacology

Gilman S.
PMID: 11575863
Clin Neuropharmacol. 2000 Nov-Dec;23(6):296-303. doi: 10.1097/00002826-200011000-00002.

The spinocerebellar ataxias (SCAs) are diseases characterized by the progressive degeneration and subsequent loss of neurons accompanied by reactive gliosis, degeneration of fibers from the deteriorating neurons, and clinical symptoms reflecting the locations of the lost neurons. The degenerative...

Cite
Gilman S. The spinocerebellar ataxias. Clin Neuropharmacol. 2000;23(6):296-303doi: 10.1097/00002826-200011000-00002.
Gilman, S. (2000). The spinocerebellar ataxias. Clinical neuropharmacology, 23(6), 296-303. https://doi.org/10.1097/00002826-200011000-00002
Gilman, S. "The spinocerebellar ataxias." Clinical neuropharmacology vol. 23,6 (2000): 296-303. doi: https://doi.org/10.1097/00002826-200011000-00002
Gilman S. The spinocerebellar ataxias. Clin Neuropharmacol. 2000 Nov-Dec;23(6):296-303. doi: 10.1097/00002826-200011000-00002. PMID: 11575863.
Copy Download .nbib Format: NLM
Stress and psychopathology: an overview.

Clinical neuropharmacology

Kalin NH.
PMID: 1498789
Clin Neuropharmacol. 1992;15:151A-152A. doi: 10.1097/00002826-199201001-00081.

No abstract available.

Cite
Kalin NH. Stress and psychopathology: an overview. Clin Neuropharmacol. 1992;15:151A-152Adoi: 10.1097/00002826-199201001-00081.
Kalin, N. H. (1992). Stress and psychopathology: an overview. Clinical neuropharmacology, 15151A-152A. https://doi.org/10.1097/00002826-199201001-00081
Kalin, N H. "Stress and psychopathology: an overview." Clinical neuropharmacology vol. 15 (1992): 151A-152A. doi: https://doi.org/10.1097/00002826-199201001-00081
Kalin NH. Stress and psychopathology: an overview. Clin Neuropharmacol. 1992;15:151A-152A. doi: 10.1097/00002826-199201001-00081. PMID: 1498789.
Copy Download .nbib Format: NLM
Vortioxetine-Induced Amenorrhea: A Case Report.

Clinical neuropharmacology

Işik M, Kurhan F, Ülkevan T, Özdemir PG.
PMID: 35029863
Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):7-8. doi: 10.1097/WNF.0000000000000490.

BACKGROUND: Vortioxetine is a novel multimodal antidepressant for the treatment of major depressive disorders and is widely used in clinical practice. Vortioxetine has a safe profile. However, there are case reports of other adverse effects in the literature. In...

Cite
Işik M, Kurhan F, Ülkevan T, et al. Vortioxetine-Induced Amenorrhea: A Case Report. Clin Neuropharmacol. 2022;45(1):7-8doi: 10.1097/WNF.0000000000000490.
Işik, M., Kurhan, F., Ülkevan, T., & Özdemir, P. G. (2022). Vortioxetine-Induced Amenorrhea: A Case Report. Clinical neuropharmacology, 45(1), 7-8. https://doi.org/10.1097/WNF.0000000000000490
Işik, Mesut, et al. "Vortioxetine-Induced Amenorrhea: A Case Report." Clinical neuropharmacology vol. 45,1 (2022): 7-8. doi: https://doi.org/10.1097/WNF.0000000000000490
Işik M, Kurhan F, Ülkevan T, Özdemir PG. Vortioxetine-Induced Amenorrhea: A Case Report. Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):7-8. doi: 10.1097/WNF.0000000000000490. PMID: 35029863.
Copy Download .nbib Format: NLM
Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum.

Clinical neuropharmacology

[No authors listed]
PMID: 35029866
Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):15. doi: 10.1097/WNF.0000000000000493.

No abstract available.

Cite
Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum. Clin Neuropharmacol. 2022;45(1):15doi: 10.1097/WNF.0000000000000493.
(2022). Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum. Clinical neuropharmacology, 45(1), 15. https://doi.org/10.1097/WNF.0000000000000493
"Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum." Clinical neuropharmacology vol. 45,1 (2022): 15. doi: https://doi.org/10.1097/WNF.0000000000000493
Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum. Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):15. doi: 10.1097/WNF.0000000000000493. PMID: 35029866.
Copy Download .nbib Format: NLM
Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence.

Clinical neuropharmacology

Takaki M, Ishikawa R, Sakamoto S, Hashimoto N, Okahisa Y, Yamada N.
PMID: 34966042
Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):11-12. doi: 10.1097/WNF.0000000000000488.

OBJECTIVE: Benzodiazepine (BZD) dependence has become a social problem and results in poor outcomes. Only a few evidence-based treatments for pharmacotherapy, including antidepressants, are recommended.METHODS: We reported about a 71-year-old man with onset of blindness at 50 years of...

Cite
Takaki M, Ishikawa R, Sakamoto S, et al. Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clin Neuropharmacol. 2022;45(1):11-12doi: 10.1097/WNF.0000000000000488.
Takaki, M., Ishikawa, R., Sakamoto, S., Hashimoto, N., Okahisa, Y., & Yamada, N. (2022). Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clinical neuropharmacology, 45(1), 11-12. https://doi.org/10.1097/WNF.0000000000000488
Takaki, Manabu, et al. "Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence." Clinical neuropharmacology vol. 45,1 (2022): 11-12. doi: https://doi.org/10.1097/WNF.0000000000000488
Takaki M, Ishikawa R, Sakamoto S, Hashimoto N, Okahisa Y, Yamada N. Mirtazapine Was Effective for a Patient With Benzodiazepine Dependence. Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):11-12. doi: 10.1097/WNF.0000000000000488. PMID: 34966042.
Copy Download .nbib Format: NLM
Immunotherapy for Alzheimer's disease and other dementias.

Clinical neuropharmacology

Boche D, Nicoll JA, Weller RO.
PMID: 16518131
Clin Neuropharmacol. 2006 Jan-Feb;29(1):22-7. doi: 10.1097/00002826-200601000-00008.

OBJECTIVE: The aim of this article is to review the role of immunotherapy in the removal of proteins which accumulate abnormally in neurodegenerative disorders associated with dementia, in particular amyloid-beta accumulation in Alzheimer's disease.RESULTS: In both transgenic mouse models...

Cite
Boche D, Nicoll JA, Weller RO. Immunotherapy for Alzheimer's disease and other dementias. Clin Neuropharmacol. 2006;29(1):22-7doi: 10.1097/00002826-200601000-00008.
Boche, D., Nicoll, J. A., & Weller, R. O. (2006). Immunotherapy for Alzheimer's disease and other dementias. Clinical neuropharmacology, 29(1), 22-7. https://doi.org/10.1097/00002826-200601000-00008
Boche, Delphine, et al. "Immunotherapy for Alzheimer's disease and other dementias." Clinical neuropharmacology vol. 29,1 (2006): 22-7. doi: https://doi.org/10.1097/00002826-200601000-00008
Boche D, Nicoll JA, Weller RO. Immunotherapy for Alzheimer's disease and other dementias. Clin Neuropharmacol. 2006 Jan-Feb;29(1):22-7. doi: 10.1097/00002826-200601000-00008. PMID: 16518131.
Copy Download .nbib Format: NLM
Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients: Erratum.

Clinical neuropharmacology

[No authors listed]
PMID: 30649028
Clin Neuropharmacol. 2019 Jan/Feb;42(1):22. doi: 10.1097/WNF.0000000000000318.

No abstract available.

Cite
Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients: Erratum. Clin Neuropharmacol. 2019;42(1):22doi: 10.1097/WNF.0000000000000318.
(2019). Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients: Erratum. Clinical neuropharmacology, 42(1), 22. https://doi.org/10.1097/WNF.0000000000000318
"Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients: Erratum." Clinical neuropharmacology vol. 42,1 (2019): 22. doi: https://doi.org/10.1097/WNF.0000000000000318
Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients: Erratum. Clin Neuropharmacol. 2019 Jan/Feb;42(1):22. doi: 10.1097/WNF.0000000000000318. PMID: 30649028; PMCID: PMC6369896.
Copy Download .nbib Format: NLM
β-Blockers for the Treatment of Misophonia and Misokinesia.

Clinical neuropharmacology

Webb J.
PMID: 35029865
Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):13-14. doi: 10.1097/WNF.0000000000000492.

ABSTRACT: Misophonia is an adverse physical and emotional reaction to certain repetitive trigger sounds, usually generated by other people. Misokinesia refers to visual triggers that are sometimes (but not always) related to trigger sounds. Despite how common and disabling...

Cite
Webb J. β-Blockers for the Treatment of Misophonia and Misokinesia. Clin Neuropharmacol. 2022;45(1):13-14doi: 10.1097/WNF.0000000000000492.
Webb, J. (2022). β-Blockers for the Treatment of Misophonia and Misokinesia. Clinical neuropharmacology, 45(1), 13-14. https://doi.org/10.1097/WNF.0000000000000492
Webb, Jadon. "β-Blockers for the Treatment of Misophonia and Misokinesia." Clinical neuropharmacology vol. 45,1 (2022): 13-14. doi: https://doi.org/10.1097/WNF.0000000000000492
Webb J. β-Blockers for the Treatment of Misophonia and Misokinesia. Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):13-14. doi: 10.1097/WNF.0000000000000492. PMID: 35029865.
Copy Download .nbib Format: NLM
Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum.

Clinical neuropharmacology

[No authors listed]
PMID: 35029866
Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):15. doi: 10.1097/WNF.0000000000000493.

No abstract available.

Cite
Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum. Clin Neuropharmacol. 2022;45(1):15doi: 10.1097/WNF.0000000000000493.
(2022). Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum. Clinical neuropharmacology, 45(1), 15. https://doi.org/10.1097/WNF.0000000000000493
"Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum." Clinical neuropharmacology vol. 45,1 (2022): 15. doi: https://doi.org/10.1097/WNF.0000000000000493
Misophonia Successfully Treated of With Fluoxetine: A Case Report: Erratum. Clin Neuropharmacol. 2022 Jan-Feb 01;45(1):15. doi: 10.1097/WNF.0000000000000493. PMID: 35029866.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries